Drug recall · May 20, 2015
Olanzapine recall
Why: Subpotent drug
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Olanzapine, Orally Disintegrating Tablets, 10 mg, a) 30-count bottle (NDC 60505-3276-03), b) 100-count blister (NDC 60505-3276-00), Rx only, Manufactured by Apotex Inc. Toronto, Ontario Canada, M9L 1T9
- Lots / codes
Lot #: a) KY2389, Exp 05/16; b) KY2388, Exp 05/16
- Quantity
- 6,467 bottles/ blister cartons
- Company
- Apotex Inc., Toronto, N/A
- Distribution
- Nationwide
- Initiated
- April 7, 2015 · Voluntary: Firm initiated
- Classified
- May 14, 2015
- Reported
- May 20, 2015
- Ended
- April 7, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Olanzapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.